2017
DOI: 10.1016/j.beha.2016.11.001
|View full text |Cite
|
Sign up to set email alerts
|

Pathology of nodal marginal zone lymphomas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
21
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 17 publications
(22 citation statements)
references
References 46 publications
1
21
0
Order By: Relevance
“…20,141 Plasma cell differentiation may be prominent, posing a problem for differential diagnosis from lymphoplasmacytic lymphoma, nodal plasmacytoma, and IgG4-related lymphadenopathy. [142][143][144][145] As indicated previously, 136 the large tumour cells are more frequently admixed than in SMZL and MALT lymphoma, which often raises the question of whether it should be diagnosed as NMZL or DLBCL histological transformation or evolution. If no overt or sheet-like proliferation of large cells is present, the preferable diagnosis of NMZL is recommended because the proportion of scattered or clustered large cells or the Ki-67 index appear to have little prognostic significance.…”
Section: Nodal Mzl (Nmzl)mentioning
confidence: 91%
See 4 more Smart Citations
“…20,141 Plasma cell differentiation may be prominent, posing a problem for differential diagnosis from lymphoplasmacytic lymphoma, nodal plasmacytoma, and IgG4-related lymphadenopathy. [142][143][144][145] As indicated previously, 136 the large tumour cells are more frequently admixed than in SMZL and MALT lymphoma, which often raises the question of whether it should be diagnosed as NMZL or DLBCL histological transformation or evolution. If no overt or sheet-like proliferation of large cells is present, the preferable diagnosis of NMZL is recommended because the proportion of scattered or clustered large cells or the Ki-67 index appear to have little prognostic significance.…”
Section: Nodal Mzl (Nmzl)mentioning
confidence: 91%
“…WHO lymphoma classification defines NMZL as a primary nodal B-cell neoplasm that morphologically resembles the extranodal (MALT) or splenic MZL types, but patients lack clinical evidence of extranodal or splenic disease. 136,137 Bone marrow involvement occurs in 30-40% of patients. This disease is challenging for pathologists to recognise because of the lack of exclusive positive immunohistochemical or molecular markers.…”
Section: Nodal Mzl (Nmzl)mentioning
confidence: 99%
See 3 more Smart Citations